Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells
- PMID: 20524851
- DOI: 10.1086/653499
Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells
Abstract
Background: Triggering Toll-like receptors (TLRs) on dendritic cells (DCs) induces inflammatory cytokine production necessary for T helper type 1 immunity. The present study investigated whether simultaneous stimulation of two TLRs that signal through the same or different pathway(s) enhances cytokine production in DCs.
Methods: Fms-like tyrosine kinase-3 ligand-generated murine DCs were used in stimulation assays with TLR agonists with or without pharmacological inhibitors of cell signaling pathways. Cytokine levels were evaluated by enzyme-linked immunosorbent assay or cytometric bead array.
Results: There was synergistic enhancement of interleukin (IL)-6 and IL-12, which were significantly inhibited by inhibitors of nuclear factor-kappaB and phosphatidylinositol 3-kinase. IL-12p40 was significantly inhibited by both p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase inhibitors, whereas IL-12p70 was inhibited by p38 MAPK inhibitor alone. IL-6 was significantly inhibited by extracellular signal-regulated kinase and, variably, by p38 MAPK and c-Jun N-terminal kinase inhibitors.
Conclusions: Production of cytokines in DCs after simultaneous stimulation of TLRs that signal through the same or different pathway(s) showed differential use of MAPK signaling pathways, yet both nuclear factor-kappaB and the phosphatidylinositol 3-kinase pathway as a positive regulator of TLR signaling were important. Our data suggest an important role for MyD88-dependent signaling pathways in TLR-mediated synergistic enhancement of inflammatory cytokine production in DCs.
Similar articles
-
Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.Mol Immunol. 2010 Jul;47(11-12):2065-73. doi: 10.1016/j.molimm.2010.04.004. Epub 2010 May 6. Mol Immunol. 2010. PMID: 20451253
-
Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.Mol Immunol. 2008 May;45(10):2734-42. doi: 10.1016/j.molimm.2008.02.010. Epub 2008 Mar 26. Mol Immunol. 2008. PMID: 18372043
-
Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.Cell Immunol. 2007 Jun;247(2):72-84. doi: 10.1016/j.cellimm.2007.07.008. Epub 2007 Oct 24. Cell Immunol. 2007. PMID: 17927969
-
Crosstalk between complement and toll-like receptors.Toxicol Pathol. 2012;40(2):174-82. doi: 10.1177/0192623311428478. Epub 2011 Nov 22. Toxicol Pathol. 2012. PMID: 22109714 Review.
-
Toll-like receptors at the ocular surface.Ocul Surf. 2008 Jul;6(3):108-16. doi: 10.1016/s1542-0124(12)70279-3. Ocul Surf. 2008. PMID: 18781257 Free PMC article. Review.
Cited by
-
Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists.Pharmaceutics. 2021 Aug 31;13(9):1374. doi: 10.3390/pharmaceutics13091374. Pharmaceutics. 2021. PMID: 34575449 Free PMC article. Review.
-
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines.Vaccines (Basel). 2015 Mar 5;3(1):148-71. doi: 10.3390/vaccines3010148. Vaccines (Basel). 2015. PMID: 26344951 Free PMC article. Review.
-
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.Front Immunol. 2018 Sep 3;9:1923. doi: 10.3389/fimmu.2018.01923. eCollection 2018. Front Immunol. 2018. PMID: 30233565 Free PMC article. Review.
-
Nano-Pulse Stimulation Treatment Inhibits Pan02 Murine Pancreatic Tumor Growth and Induces a Long-Term Adaptive Immune Response with Abscopal Effects When Combined with Immune-Enhancing Agents.Bioelectricity. 2024 Jun 12;6(2):108-117. doi: 10.1089/bioe.2024.0011. eCollection 2024 Jun. Bioelectricity. 2024. PMID: 39119566 Free PMC article.
-
Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Sci Rep. 2017 May 31;7(1):2530. doi: 10.1038/s41598-017-02804-y. Sci Rep. 2017. PMID: 28566683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
